NASDAQ · ECXWW

ECARX Holdings Inc.

$0.05 +$0.01 (+36.12%) 1D Pre-market

Key Metrics

$17.04M
Market cap
P/E · TTM
$847.86M
Revenue · TTM
−$66.04M
Net income
EPS · TTM $-0.20
Dividend yield
Free cash flow −$106.56M
Beta · 1Y -0.92
EBITDA · TTM −$47.82M
Gross margin 19.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    The stock moved +36.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 23
  • Jul 21
    From its Feb 10 high, the share price fell 46%.

    Peak close $0.07 on Feb 10; trough close $0.04 on Jul 21. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved +38.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.04 – $0.10
Avg volume · 20D48.6K
Net cash
Book value / share$-0.84
ExchangeNASDAQ
About ECARX Holdings Inc.
IPO dateDec 21, 2022
Employees1432

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.02
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 19.0%
Operating -8.0%
Net -7.8%
FCF -12.6%
ROE / ROIC 25.2% · 18.6%

Financial Health

Current ratio0.59
Quick ratio0.51
Debt / equity
Debt / EBITDA
Net cash
Working capital−$339.83M

Cash Flow · TTM

Operating CF −$94.39M
Capex −$12.17M
Free cash flow −$106.56M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-2.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings